Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities

东南合作以创新和公平的方式解决慢性病差异

基本信息

  • 批准号:
    10891968
  • 负责人:
  • 金额:
    $ 81.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-24 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary The United States continues to experience some of the worst health disparities in the world, in part due to the inability to address social drivers of health (SDoH). These SDoH, such as income, education/health literacy, and built environment, contribute to an estimated 50% of health inequities. The National Academy of Sciences, Engineering, and Medicine (NASEM) and other organizations have called for the systematic incorporation of SDoH assessment into electronic health records (EHRs) and clinical care. Further, new 2023 regulations from The Joint Commission now require SDoH screening, adding urgency to the need to study and establish best practices. However, surprisingly little research has evaluated implementation of SDoH data collection, assessed how multidisciplinary health care teams can best address SDoH in clinical practice, or measured the effects of social risk-informed care on patient outcomes in patients with chronic conditions, where health disparities are widespread. Concerns also exist about potential unintended consequences, such as administrative burden to clinics and stigmatization of patients. As a result, most practices do not address SDoH systematically, missing an important opportunity to foster health equity. The goal of this project is to develop and evaluate a multi-level initiative to collect and address SDoH as part of the clinical care of adult primary care patients with type 2 diabetes, plus hypertension and/or hyperlipidemia. The proposed research builds on the substantial preliminary work and expertise of our interdisciplinary research team in the measurement of SDoH and interventions to address them, as well as health disparities, implementation science, and health information technology. In Aim 1, we will use qualitative methods to assess the perspectives of stakeholders – investigators already involved in activities related to community engagement and social drivers, patients, clinicians, clinic staff, and community organization leaders – on the collection and use of patient-reported SDoH, how to optimize integration of SDoH information and clinical decision support tools in the EHR, and how to minimize potential barriers to implementation and unintended consequences. In Aim 2, we will implement a multi-level initiative (SDoH data collection, training and tools for health care professionals, care coordinator and pharmacist support, and community resources) and evaluate its effect on clinical outcomes, including hemoglobin A1c, blood pressure, and cholesterol. In Aim 3, we will perform a mixed-methods evaluation of implementation using the RE-AIM QuEST framework to inform scale-up and spread. This research will fill critical gaps in knowledge related to real-world implementation of SDoH data collection and provision of social risk-informed care. Findings will be relevant across a broad range of chronic medical conditions affected by social risk factors and health disparities, enhancing the project's potential for impact.
项目摘要 美国继续经历着世界上最严重的健康差距,部分原因是 无法解决健康的社会驱动因素(SDoH)。这些SDOH,如收入、教育/健康 识字率和建筑环境造成了约50%的卫生不平等。The National Academy of 科学,工程和医学(NASEM)和其他组织呼吁系统的 将SDoH评估纳入电子健康记录(EHR)和临床护理。此外,新的2023年 联合委员会的规定现在要求SDoH筛选,增加了研究和 建立最佳做法。然而,令人惊讶的是,很少有研究评估了SDoH数据的实施情况 收集,评估多学科医疗保健团队如何在临床实践中最好地解决SDoH,或 测量了社会风险知情护理对慢性病患者预后的影响, 那里的健康差距很大。人们还担心潜在的意外后果, 给诊所造成行政负担,使病人蒙受耻辱。因此,大多数做法都没有解决 SDoH系统地错过了促进健康公平的重要机会。 该项目的目标是制定和评估一个多层次的倡议,以收集和解决SDoH, 2型糖尿病合并高血压和/或高血压的成人初级保健患者的部分临床护理 高脂血症拟议的研究建立在我们的大量前期工作和专业知识的基础上。 跨学科研究小组在衡量SDoH和干预措施,以解决他们,以及 健康差距、实施科学和健康信息技术。 在目标1中,我们将使用定性方法来评估利益相关者的观点-调查人员已经 参与与社区参与和社会驱动因素、患者、临床医生、诊所工作人员有关的活动, 社区组织领导-关于收集和使用患者报告的SDoH,如何优化 在EHR中集成SDoH信息和临床决策支持工具,以及如何最大限度地减少潜在的 执行障碍和意外后果。在目标2中,我们将实施多层次举措 (SDoH针对医疗保健专业人员、护理协调员和药剂师的数据收集、培训和工具 支持和社区资源),并评估其对临床结局的影响,包括血红蛋白A1 c, 血压和胆固醇在目标3中,我们将使用 RE-AIM QuEST框架为扩大规模和推广提供信息。 这项研究将填补与SDoH数据的实际实施相关的知识的关键空白 收集和提供社会风险知情护理。研究结果将与广泛的慢性 受社会风险因素和健康差距影响的医疗条件,提高项目的潜力, 冲击

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Barriers to Community-Based Eradication of Helicobacter pylori Infection.
以社区为基础根除幽门螺杆菌感染的障碍。
Sleep-Disordered Breathing Destabilizes Ventricular Repolarization.
睡眠呼吸障碍会破坏心室复极的稳定性。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nancy J Cox其他文献

Reaching for the next branch on the biobank tree of knowledge
伸手去够生物银行知识之树上的下一个分支
  • DOI:
    10.1038/ng.3946
  • 发表时间:
    2017-09-01
  • 期刊:
  • 影响因子:
    29.000
  • 作者:
    Nancy J Cox
  • 通讯作者:
    Nancy J Cox

Nancy J Cox的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nancy J Cox', 18)}}的其他基金

FIGOR: Fellowship In Genomics Outcomes Research
FigOR:基因组结果研究奖学金
  • 批准号:
    10628304
  • 财政年份:
    2023
  • 资助金额:
    $ 81.35万
  • 项目类别:
Training Program on Genetic Variation and Human Phenotypes
遗传变异和人类表型培训计划
  • 批准号:
    10420390
  • 财政年份:
    2022
  • 资助金额:
    $ 81.35万
  • 项目类别:
Training Program on Genetic Variation and Human Phenotypes
遗传变异和人类表型培训计划
  • 批准号:
    10651837
  • 财政年份:
    2022
  • 资助金额:
    $ 81.35万
  • 项目类别:
Polygenic risk scores and health disparities: the role of blood cells immune response and evolutionary adaptation
多基因风险评分和健康差异:血细胞免疫反应和进化适应的作用
  • 批准号:
    10212768
  • 财政年份:
    2021
  • 资助金额:
    $ 81.35万
  • 项目类别:
Polygenic risk scores and health disparities: the role of blood cells immune response and evolutionary adaptation
多基因风险评分和健康差异:血细胞免疫反应和进化适应的作用
  • 批准号:
    10424445
  • 财政年份:
    2021
  • 资助金额:
    $ 81.35万
  • 项目类别:
Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities
东南合作以创新和公平的方式解决慢性病差异
  • 批准号:
    10437309
  • 财政年份:
    2021
  • 资助金额:
    $ 81.35万
  • 项目类别:
Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities
东南合作以创新和公平的方式解决慢性病差异
  • 批准号:
    10657748
  • 财政年份:
    2021
  • 资助金额:
    $ 81.35万
  • 项目类别:
Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities
东南合作以创新和公平的方式解决慢性病差异
  • 批准号:
    10494158
  • 财政年份:
    2021
  • 资助金额:
    $ 81.35万
  • 项目类别:
Polygenic risk scores and health disparities: the role of blood cells immune response and evolutionary adaptation
多基因风险评分和健康差异:血细胞免疫反应和进化适应的作用
  • 批准号:
    10613573
  • 财政年份:
    2021
  • 资助金额:
    $ 81.35万
  • 项目类别:
Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities
东南合作以创新和公平的方式解决慢性病差异
  • 批准号:
    10604586
  • 财政年份:
    2021
  • 资助金额:
    $ 81.35万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.35万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 81.35万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 81.35万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 81.35万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 81.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 81.35万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 81.35万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 81.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 81.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 81.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了